NL175882C - Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat. - Google Patents

Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat.

Info

Publication number
NL175882C
NL175882C NLAANVRAGE7803247,A NL175882DA NL175882C NL 175882 C NL175882 C NL 175882C NL 175882D A NL175882D A NL 175882DA NL 175882 C NL175882 C NL 175882C
Authority
NL
Netherlands
Prior art keywords
pharmaceutical preparation
preparation containing
inflammatory compound
compound
inflammatory
Prior art date
Application number
NLAANVRAGE7803247,A
Other languages
English (en)
Dutch (nl)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL175882C publication Critical patent/NL175882C/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
NLAANVRAGE7803247,A 1977-03-28 Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat. NL175882C (nl)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US78214477A 1977-03-28 1977-03-28
US78214377A 1977-03-28 1977-03-28
US80189677A 1977-05-31 1977-05-31
US80170777A 1977-05-31 1977-05-31
US80170577A 1977-05-31 1977-05-31
US80189577A 1977-05-31 1977-05-31
US80170477A 1977-05-31 1977-05-31
CH601678A CH645542A5 (de) 1977-03-28 1978-06-01 Entzuendungshemmende arzneimittelpraeparate.
SE7806449A SE441493B (sv) 1977-03-28 1978-06-01 Antiinflammatorisk komposition innefattande en salicylsyrabaserad, antiinflammatorisk forening och ett organofosfonat
SE8001363A SE441494B (sv) 1977-03-28 1980-02-21 Antiinflammatorisk komposition innefattande en indolbaserad, antiinflammatorisk forening och ett organofosfonat

Publications (1)

Publication Number Publication Date
NL175882C true NL175882C (nl)

Family

ID=27579075

Family Applications (2)

Application Number Title Priority Date Filing Date
NLAANVRAGE7803247,A NL175882C (nl) 1977-03-28 Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat.
NLAANVRAGE7803247,A NL175882B (nl) 1977-03-28 1978-03-28 Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7803247,A NL175882B (nl) 1977-03-28 1978-03-28 Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat.

Country Status (11)

Country Link
US (1) US4269828A (xx)
JP (1) JPS542340A (xx)
AU (1) AU524180B2 (xx)
BE (1) BE865370A (xx)
CA (1) CA1109794A (xx)
CH (1) CH645542A5 (xx)
DE (1) DE2813165C2 (xx)
FR (1) FR2385398A1 (xx)
GB (1) GB1588284A (xx)
NL (2) NL175882B (xx)
SE (2) SE441493B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1229554A (en) * 1983-04-18 1987-11-24 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition
US4602040A (en) * 1983-04-18 1986-07-22 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition
DE3324193A1 (de) * 1983-07-05 1985-01-17 Troponwerke Gmbh & Co Kg Depot-antiphlogistika
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
JPH0639449B2 (ja) * 1989-04-10 1994-05-25 エーザイ株式会社 ポリプレニル系化合物およびその製造方法ならびにそれを含有する医薬
EP0550385A1 (de) * 1991-12-19 1993-07-07 Ciba-Geigy Ag Peroral zu verabreichende pharmazeutische Zusammensetzungen, die Methandiphosphonsäure-Derivate und 18-Krone-6 Ether enthalten
CA2138366C (en) * 1992-06-30 1998-09-22 Kristine Hovancik Methods for the treatment of arthritis using phosphonates and nsaids
SE9303740L (sv) * 1993-11-12 1995-05-13 Leiras Oy Farmaceutisk komposition
US5652227A (en) * 1995-01-30 1997-07-29 Teronen; Olli Pekka Inhibition of the degradation of connective tissue matrix protein components in mammals
WO1997013519A1 (en) * 1995-10-09 1997-04-17 Russinsky Limited Esters of cyclooxygenase inhibitors and terpene derivatives as pharmaceutical products
DE19615577A1 (de) * 1996-04-19 1997-10-23 Beiersdorf Ag Verwendung von Salicin als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen
SE9703691D0 (sv) * 1997-10-10 1997-10-10 Astra Ab Pharmaceutical compositions
DE10049735A1 (de) * 2000-09-28 2002-04-18 Jenapharm Gmbh Verfahren zur Isolierung von pharmazeutisch verwertbarem Etidronat-Dinatrium
AUPR283801A0 (en) * 2001-02-01 2001-03-01 Australian National University, The Chemical compounds and methods
DK2421513T3 (en) 2009-04-24 2018-03-26 Iceutica Pty Ltd UNKNOWN FORMULATION WITH INDOMETHACIN

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3584125A (en) * 1968-12-23 1971-06-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3553314A (en) * 1968-12-23 1971-01-05 Procter & Gamble Oral compositions for calculus retardation
US3584124A (en) * 1968-12-24 1971-06-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3553315A (en) * 1968-12-24 1971-01-05 Procter & Gamble Oral compositions for calculus retardation
US3678164A (en) * 1969-02-12 1972-07-18 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3641246A (en) * 1970-01-14 1972-02-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phcosphate in animal tissue
US3662066A (en) * 1970-03-04 1972-05-09 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US4044125A (en) * 1975-07-18 1977-08-23 Eli Lilly And Company Method of stabilizing acetylsalicylic acid in the presence of d-propoxyphene hydrochloride and compositions thereof
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin

Also Published As

Publication number Publication date
US4269828A (en) 1981-05-26
JPS542340A (en) 1979-01-09
GB1588284A (en) 1981-04-23
NL7803247A (nl) 1978-10-02
CH645542A5 (de) 1984-10-15
FR2385398A1 (fr) 1978-10-27
AU524180B2 (en) 1982-09-02
AU3451178A (en) 1979-10-04
DE2813165C2 (de) 1983-12-15
SE8001363L (sv) 1980-02-21
SE441494B (sv) 1985-10-14
NL175882B (nl) 1984-08-16
SE7806449L (sv) 1979-12-02
CA1109794A (en) 1981-09-29
DE2813165A1 (de) 1978-10-12
SE441493B (sv) 1985-10-14
FR2385398B1 (xx) 1980-04-04
BE865370A (fr) 1978-09-28

Similar Documents

Publication Publication Date Title
NL175882C (nl) Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat.
NL190664B (nl) Gesubstitueerde benzhydrylpiperidinoderivaten met therapeutische werking en farmaceutische preparaten die deze verbindingen bevatten.
ATE22007T1 (de) Pharmazeutische mischung.
NO146456C (no) Fremgangsmaate for fremstilling av kapsellegeme, saerlig for medisindoseringskapsel
NL190580B (nl) Gesubstitueerde benzhydrylpiperidinederivaten met therapeutische werking en preparaten die deze stoffen bevatten.
PT69922A (de) Arzneimittel-retardform mit unloslichen porosen diffusionshullen
NO863062D0 (no) Innretning for administrering av medikamenter til pasienter.
DK128675A (de) Pharmazeutische zusammensetzung
DK393187A (da) Laegemiddel med antitumorvirkning
DE3580616D1 (de) Mitomycinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
IT8821543A0 (it) Farmaci precursori della dopamina.
ES2053768T3 (es) Tabletas masticables.
BE841121A (fr) Acides n-aryl-anthraniliques, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits acides anthraniliques
NO883500D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
NL172157C (nl) Preparaat met bloeddrukverlagende werking en de daarvoor geschikte werkzame verbindingen.
NL179873C (nl) Farmaceutisch preparaat dat als actief bestanddeel een of meer glycerylfosforylderivaten bevat.
NL192111B (nl) Geneesmiddelpreparaat met anti-inflammatoire werking.
IT8721687A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropiridin-3-carbossa ldeide, loro procedimento di preparazione e loro impiego come sostanze medicinali.
DK0450123T3 (da) Farmaceutisk præparat til topisk administration indeholdende dichlofenac-natrium
IT8020100A0 (it) Medicamento, o preparato farmaceutico, ad azione citostatica.
NO891574D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
IT8722218A0 (it) Ftalazino derivati ad attivita'farmaceutica.
IT7822316A0 (it) Composizione farmaceutica per la somministrazione di pancreatina.
FR2303555A1 (fr) Nouvel antibiotique, sa preparation et medicament le contenant
IT8020503A0 (it) Derivati della 1,1'-bifenil-2-ilalchilammina ad azione farmaceutica.